Defiance Daily Target 2X Long PURR ETF (PUR) Price & Chart
PUR ETF Chart & Stats
- Day’s Range
- $21.13 - $25.49
- 52-Week Range
- $9.66 - $48.44
- Previous Close
- $29.06
- Volume
- 159.59K
- Average Volume (3M)
- 146.11K
- AUM
- 7.26M
- NAV
- 22.95
- Expense Ratio
- 1.31%
- Holdings Count
- 3
- Beta
- -2.21
- Inception Date
- Jul 07, 2026
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 330,000
- Standard Deviation
- N/A
ETF Overview
Defiance Daily Target 2X Long PURR ETF
Defiance Daily Target 2X Long PURR ETF (Ticker: PUR) is a leveraged, sector-focused exchange‑traded fund designed to provide tactical, daily exposure to a single health care company. The fund seeks daily investment results, before fees and expenses, equal to two times (200%) the daily percentage change in the share price of Hyperliquid Strategies Inc. (NASDAQ: PURR). Category and focus - Sector: Health Care. Unlike broad health care or biotech ETFs, PUR offers concentrated, single‑name exposure to a company in the health care space, amplified through leverage. It is intended for investors who want a directional, short‑term bet on PURR’s daily price movements rather than diversified sector ownership. Key characteristics - Leverage: Targets 2x the daily return of NASDAQ: PURR, magnifying both gains and losses on a day-to-day basis. - Daily reset: The fund is rebalanced each trading day to maintain the 2x target, meaning its performance over periods longer than one day can diverge significantly from 2x the cumulative return of the underlying stock due to compounding and volatility. - Concentration: Exposure is tied to a single issuer, increasing company‑specific risk compared with multi‑company sector ETFs. - Trading convenience: Trades like an equity on the exchange, offering intraday liquidity and the ability to implement short‑term strategies through a single ticker. Risk profile and suitability PUR is intended for experienced, risk‑tolerant investors and active traders who understand leveraged and concentrated vehicles. It is generally unsuitable as a long‑term buy‑and‑hold investment because daily rebalancing, volatility drag, and fees can materially affect multi‑day returns. Prospective investors should be aware of the potential for magnified losses, path dependency of returns, and the impact of expenses before investing.